* DermTech Inc reported a quarterly adjusted loss of 58 cents per share for the quarter ended in March, higher than the same quarter last year, when the company reported EPS of $-1.02. The mean expectation of four analysts for the quarter was for a loss of 57 cents per share. Wall Street expected results to range from -59 cents to -54 cents per share.
* Revenue rose 10.6% to $3.85 million from a year ago; analysts expected $3.99 million.
* DermTech Inc's reported EPS for the quarter was a loss of 58 cents.
* The company reported a quarterly loss of $20.01 million.
* DermTech Inc shares had fallen by 11.7% this quarter and lost 64.6% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by about 0.8% in the last three months.
* In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."
* The average consensus recommendation for the medical equipment, supplies & distribution peer group is "hold."
Wall Street's median 12-month price target for DermTech Inc is $1.50 This summary was machine generated from LSEG data May 14 at 10:21 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2024 -0.57 -0.58 Missed
Dec. 31 2023 -0.56 -0.56 Met
Sep. 30 2023 -0.76 -0.57 Beat
Jun. 30 2023 -0.97 -0.99 Missed
Comments